Pratz, K. W., Sato, T., Murphy, K. M., Stine, A., Rajkhowa, T., & Levis, M. (2010). FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. American Society of Hematology.
Citação norma ChicagoPratz, Keith W., Takashi Sato, Kathleen M. Murphy, Adam Stine, Trivikram Rajkhowa, and Mark Levis. FLT3-mutant Allelic Burden and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML. American Society of Hematology, 2010.
ציטוט MLAPratz, Keith W., et al. FLT3-mutant Allelic Burden and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML. American Society of Hematology, 2010.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.